¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ȯ"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • critically ill patient
    ÁßȯÀÚ
  • cross circulation
    ±³Â÷¼øÈ¯
  • crossingover
    ±³Â÷, ±³¹è, À¯ÀüÀÚ±³È¯
  • cryptorchid
    Àẹ°íȯ-
  • cryptorchidectomy
    Àẹ°íȯÀýÁ¦(¼ú)
  • cryptorchidism
    Àẹ°íȯ(Áõ)
  • cryptorchidopexy
    °íȯ°íÁ¤(¼ú)
  • cryptorchism
    Àẹ°íȯ(Áõ)
  • cutaneous hallucination
    ÇǺÎȯ°¢
  • cycle
    1. ÁÖ±â 2. ¼øÈ¯ 3. ȸ·Î 4. °í¸® 5. Á֯ļö
  • cyclic
    ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
  • cyclic periodicity
    ¼øÈ¯Áֱ⼺
  • cyclic schizophrenia
    ¼øÈ¯ÇüÁ¤½ÅºÐ¿­º´
  • cycling
    ¼øÈ¯¼º
  • cycloid
    ¼øÈ¯Çü-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • ventilator
    1.ȯ±â±â, 2.ÀΰøÈ£Èí±â
  • vaginalitis
    °íȯÁý¸·¿°
  • alveolar ventilation
    ÆóÆ÷ȯ±â, ÇãÆÄ²Ê¸®È¯±â
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®
  • dead space ventilation
    Á×Àº°ø°£È¯±â, »ç°­È¯±â
  • noninvasive positive-pressure ventilation
    ºñħ½À¾ç¾Ðȯ±â
  • pressure-controlled ventilation
    ¾Ð·ÂÁ¶Àýȯ±â
  • testicular varicocele
    °íȯÁ¤¸Æ·ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • phantosmia
    ȯÃë, ȯ»ó³¿»õ
  • annelid
    ȯÇüµ¿¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • commutator series
    ±³È¯ÀÚ¿­
  • compensatory circulation
    (¢¡collateral circulation) °ç¼øÈ¯
  • congenital conversion nipple
    ¼±ÃµÀüȯÀ¯µÎ
  • continuous mandatory ventilation
    Áö¼ÓÇʼöȯ±â
  • control mode ventilation
    Á¶Àýȯ±â¹ý
  • controlled mechanical ventilation
    ±â°èÀûÁ¶Àýȯ±â
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • coronary circulation
    ½ÉÀ嵿¸Æ¼øÈ¯
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò.
  • angiotensin converting enzyme inbibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • anion exchange chromatography
    À½À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • anion exchange protein
    À½À̿ ±³È¯ ´Ü¹é(ÎßüµÓ±ÛÜ)
  • anion exchange resin
    À½À̿±³È¯¼öÁö
  • anisometrope
    ±¼ÀýºÎµîȯÀÚ(¡­ãÊü´íº).
  • annularis telangiectodes purpura
    ¸ð¼¼Ç÷°ü È®À强 ȯ»óÀÚ¹Ý
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ÓÞð¡Øæü½êü)ÀÌ»ó.
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ËÀ?ËÎÌ·Ëô)ÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(øËð¡Øæü½êü)ÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(̰?ËÎÌ·Ëô)ÀÌ»ó.
  • anomalous pulmonary venous return
    ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó.
  • anorchi(di)sm
    ¹«°íȯÁõ(ÙíÍÂü¯ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • circular DNA
    ȯ»ó DNA.
  • loop gap resonator
    ȯ»ó °£°Ý °ø¸í±â
  • annular psoriasis
    ȯ»ó °Ç¼±(ËëàÈ)
  • cyclarthrosis
    ȯ»ó °üÀý(ü»ßÒμï½), Â÷Ãà °üÀý(ó³õîμï½).
  • circinate balanitis
    ȯ»ó ±ÍµÎ¿°
  • circinate impetigo
    ȯ»ó ³ó°¡Áø
  • circular bandage
    ȯ»ó ºØ´ë(ü»ßÒÝÞÓá).
  • annular prurigo
    ȯ»ó ¾çÁø
  • annular granuloma
    ȯ»ó À°¾ÆÁ¾(ë¿ä´ðþ)
  • ring enhancement
    ȯ»ó Á¶¿µÁõ°­
  • annular lipoatrophy
    ȯ»ó Áö¹æ À§ÃàÁõ(ëÌßÒ ò·Û¸ ê×õêñø)
  • annular elastotic giant cell granuloma
    ȯ»ó ź·Â ¼¶À¯¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
  • annular lichen planus
    ȯ»ó ÆíÆò( ø·øÁ)ż±(÷ÄàÈ)
  • annular erythema
    ȯ»ó È«¹Ý
  • trichobasiloma cysticum annulare ³ª
    ȯ»ó(¼¼Æ÷)¸ð±âÀú¼¼Æ÷Á¾(ü»ßÒá¬øàÙ¾Ðñ î¼á¬øàðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • aortic valvular disease
    ´ëµ¿¸ÆÆÇÁúȯ(¡­òðü´).
  • aortism
    ´ëµ¿¸ÆÁúȯ(üÁú)(¡­òðü´ô÷òõ).
  • aphasi(a)c
    1. ½Ç¾î(Áõ)ÀÇ. 2. ½Ç¾îÁõȯÀÚ.
  • aphasic
    ½Ç¾îÁõÀÇ, ½Ç¾îÁõ ȯÀÚ
  • apotheter
    Á¦´ëȯ³³±â(Á¦´ëȯ³³±â).
  • apparition
    ȯ¿µ(ü³ç±)
  • appearance time
    ÃâÇö½Ã°£(õóúÞãÁÊà) ¼øÈ¯(âàü») .
  • appendices epididymidis<³ª>
    ºÎ°íȯµ¹±â.
  • appendix epididymidis
    (ºÎ°íȯºÎ¼Ó¹°)
  • appendix epididymidis
    ºÎ°íȯºÎ¼Ó¹°
  • appendix epididymis
    ºÎ°íȯ¼ö
  • appendix of epididymis
    (ºÎ°íȯºÎ¼Ó¹°)
  • appendix of testis
    °íȯºÎ¼Ó¹°
  • appendix testis
    °íȯ¼ö.
  • appendix testis
    (°íȯºÎ¼Ó¹°)
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • synchronized intermittent mandatory v., SIMV
    µ¿½Ã°£Çæ°­Á¦È¯±â
    ÔÒãÁàõÊàúÎîÜË­ð¤üµÑ¨
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • oxane ring
    ¿Á¼¼ÀÎȯ(ü»)
  • oxidation-reduction enzyme
    »êȭȯ¿ø È¿¼Ò(ß«ûùü½êªý£áÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • oxidation-reduction reaction
    »êȭȯ¿ø ¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • oxidoreductase
    "¿Á½Ãµµ¸®´ÚÅ×À̽º, »êȭȯ¿øÈ¿¼Ò(ß«ûùü½êªý£áÈ)"
  • oxidoreduction reaction
    »êȭȯ¿ø¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • permissible substitution
    Çã¿ë ġȯ(úÉé»öÇüµ)
  • permutation
    "¼ø¿­(â÷æê), ±³È¯(Îßüµ)"
  • phage conversion
    "ÆäÀÌÁö Àüȯ(ï®üµ), ÆäÀÌÁö º¯È¯(ܨüµ)"
  • Pompe's disease
    ÆûÆä Áúȯ(òðü´)
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
  • prophage-mediated conversion
    ÇÁ·ÎÆäÀÌÁö ¸Å°³ Àüȯ(ØÚË¿ï®üµ)
  • protein turnover
    ´Ü¹éÁú Àüȯ(Ó±ÛÜòõï®üµ)
  • pyrophosphate exchange
    ÆÄÀÌ·ÎÀλê(×òß«) ±³È¯(Îßüµ)
  • radical amino acid replacement
    ¶óµðÄ® ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£
  • radiation sickness
    ¹æ»ç¼±Áúȯ
  • recycle
    Àç¼øÈ¯
  • reduction
    Á¤º¹, °¨¼Ò, ȯ¿ø
  • replacement
    º¹À§, ġȯ
  • restrictive heart disease
    ±¸¼Ó¼º½ÉÁúȯ
  • restrictive lung disease
    ±¸¼Ó¼ºÆóÁúȯ
  • restrictive pulmonary disease
    ±¸¼Ó¼ºÆóÁúȯ
  • retained testicle
    Á¤·ù°íȯ
  • rheumatic disease
    ·ù¸¶Æ¼½º¼ºÁúȯ
  • rheumatic heart disease
    ·ù¸¶Æ¼½º¼º½ÉÁúȯ
  • scan converter
    ½ºÄµº¯È¯ÀåÄ¡
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷, ÀÎȯ¼¼Æ÷
  • spirochetal disease
    ½ºÇÇ·ÎÇìŸÁúȯ
  • substitution
    ġȯ, ´ë¿ë, ´ëÄ¡
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • B95.2
    Streptococcus, group D, as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ »ç½½¾Ë±Õ DÇ÷û±º
  • B95.3
    Streptococcus pneumoniae as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ Æó·Å»ç½½¾Ë±Õ
  • B95.4
    Other streptococcus as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ ±âŸ »ç½½¾Ë±Õ
  • B95.5
    Unspecified streptococcus as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ »ó¼¼ºÒ¸íÀÇ »ç½½¾Ë±Õ
  • B95.6
    Staphylococcus aureus as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ È²»ö Æ÷µµ¾Ë±Õ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cyclic AMP
    ȯ»ó AMP, °í¸®¸ð¾ç AMP, ȯ½Ä ¾Æµ¥³ë½Å ¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀ̱۸¯ AMP, cAMP
    cyclic adelenosine 3',5'-mono
  • cyclic AMP system
    ȯ»ó AMP °è
  • cycloid personality
    ¼øÈ¯º´Áú¼º ÀΰÝ
  • cyclothmic
    ¼øÈ¯±âÁú¼º
  • cyclothymic personality
    °¨Á¤ ¼øÈ¯¼º ÀΰÝ
  • delirium
    ¼¶¸Á, ȯ°¢, Âø°¢, ¸Á»ó, Çê¼Ò¸®
    ´ë³úÀÇ ÈïºÐ, ½ÅüÀûÀÎ ºÒ¾ÈÁ¤, »ç°í »ê¶õÀ» Ư¡À¸·Î ÇÏ´Â ºñ±³Àû ªÀº ±â°£ÀÇ Á¤½ÅÀû Àå¾Ö. ¼¶¸ÁÀº º¸Åë Áßµ¶ »óÅÂÀÇ ¹Ý¿µÀÌ´Ù.
  • deoxidizing
    ȯ¿ø
    È­ÇÐÀûÀ¸·Î °áÇÕµÈ »ê¼Ò¸¦ Á¦°ÅÇÏ´Â °Í.
  • dereism
    ȯ»ó±¤, ºñÇö½Ç¼º
    ³í¸®¿Í üÇè¿¡ ÀÇÇØ ȯ»óÀÌ ¾ïÁ¦µÇÁö ¸øÇϰí ÀÚÀ¯·ÎÀÌ ³ªÅ¸³ª´Â Á¤½ÅÀû Ȱµ¿¼º.
  • desoxydation
    ȯ¿ø, Å»»ê¼Ò
  • deuteropathy
    2Â÷¼º Áúȯ, ÈĹßÁõ, ¼Ó¹ßÁõ, ¼Ó¹ß¼º Áúº´
  • diadochokinesia
    ±³´ë ¿îµ¿, ±æÇ× ¹Ýº¹, º¯È¯ ¿îµ¿, ±æÇ× ¿îµ¿ ¹Ýº¹
    ÇϳªÀÇ ¿îµ¿ Ãæµ¿À» ÁßÁöÇÏ°í ±×°Í°ú Á¤¹Ý´ëÀÇ Ãæµ¿À¸·Î º¯°æÇÏ´Â ±â´É.
  • dichromat
    ÀÌ»ö½Ã ȯÀÚ
    ÀÌ»ö¼º »ö¸ÍÀÚ, ÀÌ»öÇü »ö°¢ÀÚ.
  • didymitis
    °íȯ¿°
  • diphyodont
    À̸¦ °¡´Â, ȯġÀÇ
    Å»¶ô¼º°ú ¿µ±¸¼ºÀÇ µÎ °¡Áö Ä¡¿­À» °¡Áø °Í.
  • disillusion
    °¢¼º, ȯ¸ê
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
³×Æ÷´ÏµåÁ¤10mg - »õâ
ȯÀÎÁ¦¾à
A09703201 Nemonapride
Àü¹®ÀǾàǰ | ±Þ¿©
³×Æ÷´ÏµåÁ¤3mg - »õâ
ȯÀÎÁ¦¾à
A09703191 Nemonapride
Àü¹®ÀǾàǰ | ±Þ¿©
¸ÞÇÁÁ¹Ä¸½¶ - »õâ
ȯÀÎÁ¦¾à
A09703561 Omeprazole
Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù·»Å¹ÁÖ - »õâ
ȯÀÎÁ¦¾à
A09701761 Diclofenac sodium
Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
Æå½ÅÁ¤ - »õâ
ȯÀÎÁ¦¾à
A09702471 Pefloxacin methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦
Æå½ÅÁÖ - »õâ
ȯÀÎÁ¦¾à
A09702481 Pefloxacin methanesulfonate
Àü¹®ÀǾàǰ | »èÁ¦
ÇÇÇÇÁ¬Á¤4mg - »õâ
ȯÀÎÁ¦¾à
A09700371 Perphenazine
Àü¹®ÀǾàǰ | ¹Ì»ý»ê
ȯÀÎÇǸðÁþÁ¤1mg - »õâ
ȯÀÎÁ¦¾à
A09701781 Pimozide
Àü¹®ÀǾàǰ | ¹Ì»ý»ê
ȯÀÎÇǸðÁþÁ¤4mg - »õâ
ȯÀÎÁ¦¾à
A09701791 Pimozide
Àü¹®ÀǾàǰ | ¹Ì»ý»ê
ȯÀÎŰ´©ÇÁ¸±Á¤7.5mg - »õâ
ȯÀÎÁ¦¾à
A09703151 Quinupramine
Àü¹®ÀǾàǰ | »èÁ¦
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • fantastical
    ȯ»óÀûÀÎ
  • jubilant
    ȯ¼ºÀ» ¿Ã¸®´Â
  • laicize
    ȯ¼Ó(¼ÓÈ­)½ÃŰ´Ù;¼ÓÀο¡°Ô ¸Ã±â´Ù;(°øÁ÷ µîÀ»)¼ÓÀο¡°Ô °³¹æÇÏ´Ù
  • secularize
    ȯ¼Ó½ÃŰ´Ù;¼Ó¿ëÀ¸·Î Á¦°øÇÏ´Ù;...À» Á¾±³¿¡¼­ ºÐ¸®½ÃŰ´Ù
  • photism
    ȯ½Ã
  • ingratiate
    ȯ½ÉÀ» »ç´Ù
  • ingratiate
    ȯ½ÉÀ» »ç´Ù;..ÀÇ ºñÀ§¸¦ ¸ÂÃß´Ù
  • make up to
    ȯ½ÉÀ» »ç·Á°íÇÏ´Ù; Á¢±ÙÇÏ´Ù
  • pillbox
    ȯ¾à °©;ÀÛÀº ¿ä»õ;Åäġī
  • pilular
    ȯ¾àÀÇ
  • pilulous
    ȯ¾àÀÇ
  • pilular
    ȯ¾àÀÇ
  • stonehenge
    ȯ¿­¼®ÁÖ
  • phantasmagoric
    ȯ¿µ °°Àº;ÁÖ¸¶µî°°ÀÌ º¯ÇÏ´Â
  • glad hand
    ȯ¿µ(ÀÇ ¼Õ)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Benadryl
    º£³ªµå¸±;(µÎµå·¯±â,¾Ë·¹¸£±â¼º Áúȯ¿ë)
  • Bikini
    ºñŰ´ÏȯÃÊ(¸¶¼£ ±ºµµÀÇ);(ÅõÇǽºÀÇ)¿©ÀÚ ¼ö¿µº¹
  • CCU
    communication control unit;coronary care unit °ü(»ó)Áúȯ ÁýÁß Ä¡·á º´µ¿
  • Canal Zone
    ÆÄ³ª¸¶ ¿îÇÏ Áö´ë(2000³â¿¡ ¹Ì±¹ÀÌ ÆÄ³ª¸¶¿¡ ¹Ýȯ ¿¹Á¤)
  • Christmasbox
    Å©¸®½º¸¶½º¼±¹°(ÃàÇϱÝ)(»çȯ.¿ìÆí Áý¹è¿øµî¿¡°Ô ÁÖ´Â)
  • Cockaigne
    ȯ¶ô°æ;·±´ø
  • Collins
    ȯ´ë¿¡ ´ëÇÑ ÀλçÀå;ÁøÀ» ź À½·á(ĬÅ×ÀÏÀÇ ÀÏÁ¾)
  • D/A converter
    DAº¯È¯±â(µðÁöÅÐ ½ÅÈ£¸¦ ¾Æ³¯·Î±× ½ÅÈ£·Î º¯È¯)
  • DMT
    dimethyltryptamine(ȯ°¢Á¦)
  • Dalai Lama
    ´Þ¶óÀ̶ó¸¶(Ƽº£Æ®ÀÇ È¯ºÒ)
  • Don Juan
    µ·È¯;½ºÆäÀÎÀÇ ¹æÅÁÇÑ ±ÍÁ·
  • Dr,Feelgood
    °¢¼ºÁ¦¸¦ Á¤±âÀûÀ¸·Î ¸Ô¿© ȯÀÚ¸¦ ±âºÐ ÁÁ°Ô ¸¸µå´Â ÀÇ»ç
  • ECLSS
    environmental control and life support system;ȯ°æ Á¦¾î;»ý¸í À¯Áö ½Ã½ºÅÛ
  • ED
    effectove dpse.(¾àÀÇ)À¯È¿·®;environmental disruption ȯ°æ ÆÄ±«
  • EPA
    Environmental Protection Agency(¹Ì)ȯ°æ º¸È£Ã»
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÅëÇÕ°Ë»ö ¿Ï·á